MAP2K4 and triple-negative breast carcinoma: Inhibition of MKK4 and MKK7 was investigated in the triple-negative breast cancer line MDA-MB-231 as the genetic knockdown of MKK4 in MDA-MB-231 resulted in a suppressed tumor growth in a mouse xenograft model [63].